The Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung Disease @checkrare
The Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung Disease  @checkrare
Uploaded November 2026 | Updated November 2026, 3 days ago
Parth Rali, MD, MBBS, FCCP, pulmonologist at Temple Health, discusses interim findings from the PHINDER study evaluating pulmonary hypertension (PH) screening strategies in patients with interstitial lung disease (ILD).
The Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung DiseaseThe Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung DiseaseFabry Disease: Patients Real-World Problems and How to ManageLipodystrophy Research Presented at ENDO 2026Diagnosis and Treatment of IGF-1 DeficiencyPhase 2a GATEWAY Trial of PORT-77 in Patients With Erythropoietic Protoporphyria Shows PromiseEpisode 1: FDA Advisory Board’s Concerns About New Duchenne Drug, Brain Fog in Immune Thrombocyto...Approval of Imaavy (Nipocalimab) and its Impact on Patients With Warm Autoimmune Hemolytic AnemiaFDA Approves Multiple Myeloma Drug;  FDA Denies Neuroendocrine Drug; Safety Concerns For Prader-W...Follow-Up Data of Safusidenib in Patients With IDH-Mutant GliomasWhat the Approval of IMAAVY Means for Patients With wAIHAUltragenyx Sells PRV for $210M | The CheckRare Brief Ep 11
CheckRare |

The Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung Disease

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER